|
source DB |
source ID
|
text
|
size
|
updated at |
|
# proj.
|
|
# Ann.
|
updated_at |
| PubMed |
18818423 |
Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-h |
1.77 KB |
2019-05-30 |
|
52 |
|
0 |
2021-01-19
|
| PubMed |
29579213 |
Global aspects of viral glycosylation.
Enveloped viruses encompass some of the most common human pat |
1.83 KB |
2019-05-30 |
|
25 |
|
0 |
2021-01-19
|
| PubMed |
32363391 |
Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.
T |
1.58 KB |
2020-05-07 |
|
24 |
|
0 |
2021-01-19
|
| PubMed |
32363402 |
How glycosylation affects glycosylation: the role of N-glycans in glycosyltransferase activity.
N-gl |
1.21 KB |
2021-01-16 |
|
23 |
|
0 |
2021-01-19
|
| PubMed |
32518941 |
Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycope |
1.87 KB |
2020-06-21 |
|
26 |
|
0 |
2021-01-19
|
| PubMed |
32651954 |
Glucuronyl C5-epimerase is crucial for epithelial cell maturation during embryonic lung development. |
1.29 KB |
2021-01-16 |
|
24 |
|
0 |
2021-01-19
|
| PubMed |
32829416 |
The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as an |
145 Bytes |
2021-01-16 |
|
24 |
|
0 |
2021-01-19
|
| PubMed |
32886791 |
Site-specific characterisation of SARS-CoV-2 spike glycoprotein receptor binding domain.
The novel c |
812 Bytes |
2020-09-23 |
|
36 |
|
0 |
2021-01-19
|
| PubMed |
32985653 |
The iminosugars celgosivir, castanospermine and UV-4 inhibit SARS-CoV-2 replication.
The severe acut |
1.68 KB |
2021-01-16 |
|
23 |
|
0 |
2021-01-19
|
| PubMed |
33021626 |
Structure, Dynamics, and Interactions of GPI-Anchored Human Glypican-1 with Heparan Sulfates in a Me |
1.11 KB |
2021-01-16 |
|
24 |
|
0 |
2021-01-19
|
